Business Context and Reporting Period
Company: Chemed Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2001
Business Overview: Chemed operates through four primary segments: Roto-Rooter (plumbing and drain cleaning), Patient Care (hospice services), Service America (facility services), and Cadre Computer (software and IT services).
Key Financial Metrics
| Metric (in thousands) | Q1 2001 | Q1 2000 |
|---|---|---|
| Service Revenues and Sales | $123,281 | $121,534 |
| Income from Operations | $7,348 | $7,539 |
| Net Income | $4,510 | $4,902 |
| Earnings Per Share (Basic) | $0.46 | $0.49 |
| Earnings Per Share (Diluted) | $0.46 | $0.48 |
| Net Cash from Operating Activities | $9,969 | $9,768 |
| Cash and Cash Equivalents (End of Period) | $14,864 | $13,825 |
| Total Debt (Current + Long-term) | $72,617 | N/A |
| Unused Lines of Credit | $100,200 | N/A |
Note: Total Debt calculated as Current portion of long-term debt ($14,323) + Long-term debt ($58,294).
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 1.4% year-over-year, driven by a 6% increase in the Patient Care segment and a 1% increase in Roto-Rooter. This was offset by declines in Service America (-5%) and Cadre Computer (-3%).
- Profitability Decline: Net income decreased 8% to $4.51 million. The decline was primarily attributed to lower earnings in the Roto-Rooter segment and a reduction in "Other income - net" due to losses on nonqualified benefit plan assets compared to gains in the prior year.
- Segment Margins:
- Roto-Rooter: Aftertax margin decreased from 6.9% to 6.0% due to lower gross margins and a $189,000 loss from divesting a non-performing branch.
- Patient Care: Margin improved from 1.2% to 1.7% due to higher gross margins.
- Service America: Margin improved from 1.7% to 2.6% despite revenue declines, as the company exited less profitable contracts.
- Cadre Computer: Recorded a loss of $116,000 (margin -5.6%) after discontinuing a software development line.
- Cash Flow: Operating cash flow increased slightly to $9.97 million. Investing cash outflows decreased significantly to $3.56 million (from $14.68 million) as there were no business combination acquisitions in Q1 2001.
Outlook, Risks, and Contingencies
- Legal Contingency (DOL Investigation): The U.S. Department of Labor initiated an investigation into Roto-Rooter's pay practices, specifically regarding overtime exemptions for service technicians. The Company intends to defend the matter vigorously but cannot currently estimate potential liability.
- Investment in Vitas Healthcare: Chemed holds $27 million in redeemable preferred stock of Vitas Healthcare. Vitas refinanced its debt in April 2001, extending the maturity of Chemed's preferred stock to April 1, 2007. Management believes the investment is fully recoverable with no impairment.
- Liquidity: Management considers liquidity satisfactory, citing approximately $100.2 million in unused lines of credit.
- Accounting Standards: Adoption of SFAS 133 (Derivatives) is expected to have an insignificant impact as the Company does not use derivative instruments.
Investor Verification Checklist
- DOL Investigation Outcome: Monitor the status of the Department of Labor investigation regarding Roto-Rooter overtime pay, as a loss of exemption could materially impact labor costs.
- Roto-Rooter Margin Recovery: Verify if the 6.0% margin in Q1 2001 is a temporary anomaly or a structural shift, given the divestment of the non-performing branch.
- Cadre Computer Turnaround: Assess the long-term viability of the Cadre Computer segment following the discontinuation of its software development line and the resulting Q1 loss.
- Vitas Healthcare Performance: Review Vitas' operating results to ensure the $27 million investment remains fully recoverable as management asserts.